uniQure director awarded RSUs, small tax-driven sale

uniQure N.V. director David D. Meek reported a mix of equity awards and a small share sale.

Rhea-AI Filing Summary

uniQure N.V. director David D. Meek reported a mix of equity awards and a small share sale. He received 7,550 restricted share units under the company’s 2014 Share Incentive Plan, each representing one Ordinary Share that vests in full on the first anniversary of the grant, subject to continued service.

Meek was also granted stock options for 13,980 Ordinary Shares at an exercise price of $26.82 per share, vesting 100% after one year and expiring on June 10, 2036. In a separate transaction, 1,993 Ordinary Shares were sold at a weighted average price of $27.06 solely to cover estimated withholding taxes upon RSU vesting, pursuant to automatic instructions, leaving him with 39,747 shares held directly.

Insider Trade Summary

Net Seller: 1,993 shares

Net Sell 3 txns

Insider Meek David D.

Role Director

Sold 1,993 shs ($54K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	1,993	$27.06	$54K
Grant/Award	Stock Option (Right to Buy)	13,980	$0.00	$0.00
Grant/Award	Ordinary Shares	7,550	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 13,980 contracts (Direct); Ordinary Shares — 39,747 shares (Direct)

Footnotes (4)

1. F1. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
2. F2. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
4. F4. The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Key Figures

Shares sold: 1,993 shares Sale price: $27.06 per share Shares held after sale: 39,747 shares +4 more

7 metrics

Shares sold 1,993 shares Open-market sale on June 11, 2026 to cover taxes

Sale price $27.06 per share Weighted average price; trades from $26.92 to $27.25

Shares held after sale 39,747 shares Ordinary Shares directly owned following transactions

RSUs granted 7,550 units Restricted share units vesting 100% after one year

Options granted 13,980 options Stock options for Ordinary Shares granted June 10, 2026

Option strike price $26.82 per share Exercise price for stock option grant expiring June 10, 2036

Option expiration June 10, 2036 Expiration date of stock option grant

Key Terms

restricted share units, Stock Option (Right to Buy), weighted average price, withholding taxes, +1 more

5 terms

restricted share units financial

"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" with an exercise price of 26.8200"

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

withholding taxes financial

"shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes"

Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.

2014 Share Incentive Plan financial

"granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did uniQure (QURE) director David Meek report?

David Meek reported receiving restricted share units and stock options, plus a small sale of shares. The sale covered tax withholding upon vesting and was executed automatically under preset instructions, rather than as a discretionary trade in uniQure stock.

How many uniQure (QURE) shares did David Meek sell in this Form 4?

David Meek sold 1,993 Ordinary Shares at a weighted average price of $27.06. The sale occurred in multiple trades between $26.92 and $27.25 and was made solely to cover estimated withholding taxes tied to RSU vesting.

What equity awards did David Meek receive from uniQure (QURE)?

He received 7,550 restricted share units and stock options for 13,980 Ordinary Shares at a $26.82 exercise price. Both awards vest 100% on the first anniversary of the grant date, assuming his continued relationship with uniQure through that date.

Were David Meek’s uniQure (QURE) share sales discretionary trades?

No. The Form 4 states the 1,993 shares were sold automatically under RSU agreement instructions to cover estimated withholding taxes. It specifically notes the sale was not a discretionary trade initiated by David Meek in the open market.

How many uniQure (QURE) shares does David Meek hold after these transactions?

Following the reported transactions, David Meek directly holds 39,747 Ordinary Shares of uniQure. In addition, he holds stock options for 13,980 underlying Ordinary Shares that vest in full one year after the grant date, subject to continued service.

What is the vesting schedule for David Meek’s uniQure (QURE) RSUs and options?

Both the 7,550 restricted share units and the 13,980-share stock option grant vest 100% on the first anniversary of the grant date. Vesting is contingent on David Meek maintaining his relationship with uniQure through that one-year vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 06:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meek David D.

(Last) (First) (Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM 1105BP

(City) (State) (Zip)

NETHERLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/10/2026		A		7,550(1)	A	$0	41,740	D
Ordinary Shares	06/11/2026		S(2)		1,993(2)	D	$27.06(3)	39,747	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$26.82	06/10/2026		A		13,980		(4)	06/10/2036	Ordinary Shares	13,980	$0	13,980	D

Explanation of Responses:

1. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

2. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

4. The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

	/s/ Christian Klemt, Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)